Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
IMIDACLOPRID
Bayer Limited
QP53AX17
IMIDACLOPRID
40 Milligram
Spot On Solution
POM
Feline, Rabbits
Imidacloprid
Ectoparasiticide
Authorised
2012-02-24
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.4 ml pipette contains: ACTIVE SUBSTANCE: Imidacloprid 40 mg EXCIPIENT(S): Butylhydroxytoluene (E 321) 0.4 mg Benzyl alcohol (E 1519) 332.8 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Spot-on solution Clear yellow to slightly brownish solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and pet rabbits 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For cats of less than 4 kg: Prevention and treatment of flea _(Ctenocephalides felis) _infestations For pet rabbits of less than 4 kg: Treatment of flea infestations Fleas are killed within one day following treatment. One treatment prevents further flea infestation for three to four weeks on cats and up to one week on pet rabbits. The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD) in cats, where this has been previously diagnosed by a veterinary surgeon. 4.3 CONTRAINDICATIONS Do not treat unweaned kittens of less than 8 weeks of age. Do not use on pet rabbits of less than 10 weeks of age. Do not use in case of hypersensitivity to the active substance or to any of the excipients. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 28/10/2016_ _CRN 7023723_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Re-infestation from emergence of new fleas in the environment may continue to occur for six weeks or longer after treatment is initiated. More than one treatment may therefore be required, depending on the level of fleas in t Прочитайте повний документ